questionsmedicales.fr
Maladies cardiovasculaires
Maladies vasculaires
Embolie et thrombose
Thromboembolie
Thromboembolisme veineux
Thromboembolisme veineux : Questions médicales fréquentes
Termes MeSH sélectionnés :
Diagnostic
5
Thromboembolie veineuse
Échographie Doppler
Tests sanguins
D-dimère
Angiographie
Échographie
Scanner
Embolie pulmonaire
Diagnostic
Score de Wells
Évaluation du risque
Thromboembolie veineuse
Symptômes
5
Symptômes
Douleur
Gonflement
Embolie pulmonaire
Essoufflement
Douleur thoracique
Asymptomatique
Thromboembolie veineuse
Symptômes
Gonflement
Douleur
Thromboembolie veineuse
Localisation
Symptômes
Thromboembolie veineuse
Prévention
5
Prévention
Exercice
Anticoagulants
Bas de compression
Circulation sanguine
Prévention
Chirurgie
Immobilisation
Prévention
Voyages
Risque
Thromboembolie veineuse
Activité physique
Risque
Prévention
Traitements
5
Anticoagulants
Thrombolyse
Chirurgie
Anticoagulants
Thromboembolie veineuse
Traitement
Thrombolyse
Embolie pulmonaire
Traitement
Effets secondaires
Anticoagulants
Saignements
Prévention
Anticoagulants
Thromboembolie veineuse
Complications
5
Complications
Embolie pulmonaire
Syndrome post-thrombotique
Embolie pulmonaire
Urgence médicale
Complications
Syndrome post-thrombotique
Complications
Thromboembolie veineuse
Problèmes cardiaques
Embolie pulmonaire
Complications
Gestion
Suivi médical
Complications
Facteurs de risque
5
Facteurs de risque
Obésité
Antécédents familiaux
Âge
Risque
Thromboembolie veineuse
Grossesse
Risque
Thromboembolie veineuse
Antécédents
Risque
Thromboembolie veineuse
Tabagisme
Facteurs de risque
Thromboembolie veineuse
{
"@context": "https://schema.org",
"@graph": [
{
"@type": "MedicalWebPage",
"name": "Thromboembolisme veineux : Questions médicales les plus fréquentes",
"headline": "Thromboembolisme veineux : Comprendre les symptômes, diagnostics et traitements",
"description": "Guide complet et accessible sur les Thromboembolisme veineux : explications, diagnostics, traitements et prévention. Information médicale validée destinée aux patients.",
"datePublished": "2024-07-21",
"dateModified": "2025-04-17",
"inLanguage": "fr",
"medicalAudience": [
{
"@type": "MedicalAudience",
"name": "Grand public",
"audienceType": "Patient",
"healthCondition": {
"@type": "MedicalCondition",
"name": "Thromboembolisme veineux"
},
"suggestedMinAge": 18,
"suggestedGender": "unisex"
},
{
"@type": "MedicalAudience",
"name": "Médecins",
"audienceType": "Physician",
"geographicArea": {
"@type": "AdministrativeArea",
"name": "France"
}
},
{
"@type": "MedicalAudience",
"name": "Chercheurs",
"audienceType": "Researcher",
"geographicArea": {
"@type": "AdministrativeArea",
"name": "International"
}
}
],
"reviewedBy": {
"@type": "Person",
"name": "Dr Olivier Menir",
"jobTitle": "Expert en Médecine",
"description": "Expert en Médecine, Optimisation des Parcours de Soins et Révision Médicale",
"url": "/static/pages/docteur-olivier-menir.html",
"alumniOf": {
"@type": "EducationalOrganization",
"name": "Université Paris Descartes"
}
},
"isPartOf": {
"@type": "MedicalWebPage",
"name": "Thromboembolie",
"url": "https://questionsmedicales.fr/mesh/D013923",
"about": {
"@type": "MedicalCondition",
"name": "Thromboembolie",
"code": {
"@type": "MedicalCode",
"code": "D013923",
"codingSystem": "MeSH"
},
"identifier": {
"@type": "PropertyValue",
"propertyID": "MeSH Tree",
"value": "C14.907.355.590"
}
}
},
"about": {
"@type": "MedicalCondition",
"name": "Thromboembolisme veineux",
"alternateName": "Venous Thromboembolism",
"code": {
"@type": "MedicalCode",
"code": "D054556",
"codingSystem": "MeSH"
}
},
"author": [
{
"@type": "Person",
"name": "None None",
"url": "https://questionsmedicales.fr/author/None%20None",
"affiliation": {
"@type": "Organization",
"name": ""
}
},
{
"@type": "Person",
"name": "Jean M Connors",
"url": "https://questionsmedicales.fr/author/Jean%20M%20Connors",
"affiliation": {
"@type": "Organization",
"name": "Division of Hematology, Department of Medicine, Brigham and Women's Hospital, Harvard Medical School, Boston, MA, USA."
}
},
{
"@type": "Person",
"name": "Francis Couturaud",
"url": "https://questionsmedicales.fr/author/Francis%20Couturaud",
"affiliation": {
"@type": "Organization",
"name": "CHU Brest, Département de Médecine Interne et Pneumologie, Brest, France; Univ_Brest, INSERM U1304-GETBO, CIC INSERM 1412, F29609 Brest; FCRIN INNOVTE network, Saint-Etienne, France. Electronic address: francis.couturaud@chu-brest.fr."
}
},
{
"@type": "Person",
"name": "Susan R Kahn",
"url": "https://questionsmedicales.fr/author/Susan%20R%20Kahn",
"affiliation": {
"@type": "Organization",
"name": "Department of Medicine, McGill University, Montreal, QC, Canada; Division of Internal Medicine and Division of Clinical Epidemiology, Jewish General Hospital/Lady Davis Institute, Montreal, QC, Canada."
}
},
{
"@type": "Person",
"name": "Marc Blondon",
"url": "https://questionsmedicales.fr/author/Marc%20Blondon",
"affiliation": {
"@type": "Organization",
"name": "Service d'angiologie et d'hémostase, HUG, 1211 Genève 14, et Faculté de médecine, Université de Genève, 1211 Genève 4."
}
}
],
"citation": [
{
"@type": "ScholarlyArticle",
"name": "Identification of lncRNA expression profiles in pediatric localized scleroderma.",
"datePublished": "2022-09-20",
"url": "https://questionsmedicales.fr/article/35980595",
"identifier": {
"@type": "PropertyValue",
"propertyID": "DOI",
"value": "10.1111/jocd.15318"
}
},
{
"@type": "ScholarlyArticle",
"name": "Connective tissue nevus misdiagnosed as juvenile localized scleroderma.",
"datePublished": "2023-10-17",
"url": "https://questionsmedicales.fr/article/37848914",
"identifier": {
"@type": "PropertyValue",
"propertyID": "DOI",
"value": "10.1186/s12969-023-00913-9"
}
},
{
"@type": "ScholarlyArticle",
"name": "Juvenile localized scleroderma: A single-centre experience from India.",
"datePublished": "2022-12-03",
"url": "https://questionsmedicales.fr/article/36413107",
"identifier": {
"@type": "PropertyValue",
"propertyID": "DOI",
"value": "10.1111/jdv.18765"
}
},
{
"@type": "ScholarlyArticle",
"name": "Endpoints and outcomes for localized scleroderma/morphea: a scoping literature review.",
"datePublished": "2024-08-21",
"url": "https://questionsmedicales.fr/article/39169409",
"identifier": {
"@type": "PropertyValue",
"propertyID": "DOI",
"value": "10.1186/s12969-024-01014-x"
}
},
{
"@type": "ScholarlyArticle",
"name": "Narrow-band reflectance spectrophotometry and infrared thermography for assessment of skin lesions in localized scleroderma.",
"datePublished": "2022-08-17",
"url": "https://questionsmedicales.fr/article/35925826",
"identifier": {
"@type": "PropertyValue",
"propertyID": "DOI",
"value": "10.1111/jdv.18483"
}
}
],
"breadcrumb": {
"@type": "BreadcrumbList",
"itemListElement": [
{
"@type": "ListItem",
"position": 1,
"name": "questionsmedicales.fr",
"item": "https://questionsmedicales.fr"
},
{
"@type": "ListItem",
"position": 2,
"name": "Maladies cardiovasculaires",
"item": "https://questionsmedicales.fr/mesh/D002318"
},
{
"@type": "ListItem",
"position": 3,
"name": "Maladies vasculaires",
"item": "https://questionsmedicales.fr/mesh/D014652"
},
{
"@type": "ListItem",
"position": 4,
"name": "Embolie et thrombose",
"item": "https://questionsmedicales.fr/mesh/D016769"
},
{
"@type": "ListItem",
"position": 5,
"name": "Thromboembolie",
"item": "https://questionsmedicales.fr/mesh/D013923"
},
{
"@type": "ListItem",
"position": 6,
"name": "Thromboembolisme veineux",
"item": "https://questionsmedicales.fr/mesh/D054556"
}
]
}
},
{
"@type": "MedicalWebPage",
"name": "Article complet : Thromboembolisme veineux - Questions et réponses",
"headline": "Questions et réponses médicales fréquentes sur Thromboembolisme veineux",
"description": "Une compilation de questions et réponses structurées, validées par des experts médicaux.",
"datePublished": "2025-05-14",
"inLanguage": "fr",
"hasPart": [
{
"@type": "MedicalWebPage",
"name": "Diagnostic",
"headline": "Diagnostic sur Thromboembolisme veineux",
"description": "Comment diagnostiquer un thromboembolisme veineux ?\nQuels tests sont utilisés pour confirmer un TEV ?\nQuels signes cliniques indiquent un TEV ?\nLe scanner est-il utile pour le TEV ?\nComment évaluer le risque de TEV ?",
"url": "https://questionsmedicales.fr/mesh/D054556?mesh_terms=Scleroderma,+Localized#section-diagnostic"
},
{
"@type": "MedicalWebPage",
"name": "Symptômes",
"headline": "Symptômes sur Thromboembolisme veineux",
"description": "Quels sont les symptômes d'un TEV ?\nComment se manifeste une embolie pulmonaire ?\nLe TEV peut-il être asymptomatique ?\nQuels signes alertent sur un TEV ?\nLes symptômes varient-ils selon l'emplacement ?",
"url": "https://questionsmedicales.fr/mesh/D054556?mesh_terms=Scleroderma,+Localized#section-symptômes"
},
{
"@type": "MedicalWebPage",
"name": "Prévention",
"headline": "Prévention sur Thromboembolisme veineux",
"description": "Comment prévenir le TEV ?\nLes bas de compression aident-ils ?\nQuand est-il crucial de prévenir le TEV ?\nLes voyages longs augmentent-ils le risque ?\nL'activité physique réduit-elle le risque ?",
"url": "https://questionsmedicales.fr/mesh/D054556?mesh_terms=Scleroderma,+Localized#section-prévention"
},
{
"@type": "MedicalWebPage",
"name": "Traitements",
"headline": "Traitements sur Thromboembolisme veineux",
"description": "Quels traitements sont disponibles pour le TEV ?\nComment fonctionnent les anticoagulants ?\nQuand utiliser la thrombolyse ?\nQuels sont les effets secondaires des anticoagulants ?\nLe traitement préventif est-il nécessaire ?",
"url": "https://questionsmedicales.fr/mesh/D054556?mesh_terms=Scleroderma,+Localized#section-traitements"
},
{
"@type": "MedicalWebPage",
"name": "Complications",
"headline": "Complications sur Thromboembolisme veineux",
"description": "Quelles sont les complications du TEV ?\nL'embolie pulmonaire est-elle grave ?\nQu'est-ce que le syndrome post-thrombotique ?\nLe TEV peut-il entraîner des problèmes cardiaques ?\nComment gérer les complications du TEV ?",
"url": "https://questionsmedicales.fr/mesh/D054556?mesh_terms=Scleroderma,+Localized#section-complications"
},
{
"@type": "MedicalWebPage",
"name": "Facteurs de risque",
"headline": "Facteurs de risque sur Thromboembolisme veineux",
"description": "Quels sont les principaux facteurs de risque du TEV ?\nL'âge influence-t-il le risque de TEV ?\nLes femmes enceintes sont-elles à risque ?\nLes antécédents de TEV augmentent-ils le risque ?\nLe tabagisme est-il un facteur de risque ?",
"url": "https://questionsmedicales.fr/mesh/D054556?mesh_terms=Scleroderma,+Localized#section-facteurs de risque"
}
]
},
{
"@type": "FAQPage",
"mainEntity": [
{
"@type": "Question",
"name": "Comment diagnostiquer un thromboembolisme veineux ?",
"position": 1,
"acceptedAnswer": {
"@type": "Answer",
"text": "Le diagnostic repose sur l'évaluation clinique, l'échographie Doppler et les tests sanguins."
}
},
{
"@type": "Question",
"name": "Quels tests sont utilisés pour confirmer un TEV ?",
"position": 2,
"acceptedAnswer": {
"@type": "Answer",
"text": "Les tests incluent l'échographie, le D-dimère et parfois l'angiographie."
}
},
{
"@type": "Question",
"name": "Quels signes cliniques indiquent un TEV ?",
"position": 3,
"acceptedAnswer": {
"@type": "Answer",
"text": "Les signes incluent douleur, œdème, rougeur et chaleur dans la zone affectée."
}
},
{
"@type": "Question",
"name": "Le scanner est-il utile pour le TEV ?",
"position": 4,
"acceptedAnswer": {
"@type": "Answer",
"text": "Oui, le scanner thoracique peut détecter une embolie pulmonaire associée."
}
},
{
"@type": "Question",
"name": "Comment évaluer le risque de TEV ?",
"position": 5,
"acceptedAnswer": {
"@type": "Answer",
"text": "Des scores comme le score de Wells aident à évaluer le risque de TEV."
}
},
{
"@type": "Question",
"name": "Quels sont les symptômes d'un TEV ?",
"position": 6,
"acceptedAnswer": {
"@type": "Answer",
"text": "Les symptômes incluent douleur, gonflement, chaleur et rougeur dans la jambe."
}
},
{
"@type": "Question",
"name": "Comment se manifeste une embolie pulmonaire ?",
"position": 7,
"acceptedAnswer": {
"@type": "Answer",
"text": "Elle se manifeste par une douleur thoracique, essoufflement et parfois toux avec sang."
}
},
{
"@type": "Question",
"name": "Le TEV peut-il être asymptomatique ?",
"position": 8,
"acceptedAnswer": {
"@type": "Answer",
"text": "Oui, certains cas de TEV peuvent ne présenter aucun symptôme visible."
}
},
{
"@type": "Question",
"name": "Quels signes alertent sur un TEV ?",
"position": 9,
"acceptedAnswer": {
"@type": "Answer",
"text": "Un gonflement soudain d'une jambe et une douleur intense sont des signes d'alerte."
}
},
{
"@type": "Question",
"name": "Les symptômes varient-ils selon l'emplacement ?",
"position": 10,
"acceptedAnswer": {
"@type": "Answer",
"text": "Oui, les symptômes peuvent varier selon que le caillot est dans une veine profonde ou pulmonaire."
}
},
{
"@type": "Question",
"name": "Comment prévenir le TEV ?",
"position": 11,
"acceptedAnswer": {
"@type": "Answer",
"text": "La prévention inclut l'exercice régulier, l'hydratation et l'utilisation d'anticoagulants si nécessaire."
}
},
{
"@type": "Question",
"name": "Les bas de compression aident-ils ?",
"position": 12,
"acceptedAnswer": {
"@type": "Answer",
"text": "Oui, les bas de compression aident à améliorer la circulation sanguine et à prévenir le TEV."
}
},
{
"@type": "Question",
"name": "Quand est-il crucial de prévenir le TEV ?",
"position": 13,
"acceptedAnswer": {
"@type": "Answer",
"text": "Après une chirurgie ou lors d'une immobilisation prolongée, la prévention est cruciale."
}
},
{
"@type": "Question",
"name": "Les voyages longs augmentent-ils le risque ?",
"position": 14,
"acceptedAnswer": {
"@type": "Answer",
"text": "Oui, les voyages prolongés en position assise augmentent le risque de TEV."
}
},
{
"@type": "Question",
"name": "L'activité physique réduit-elle le risque ?",
"position": 15,
"acceptedAnswer": {
"@type": "Answer",
"text": "Oui, l'activité physique régulière aide à réduire le risque de formation de caillots."
}
},
{
"@type": "Question",
"name": "Quels traitements sont disponibles pour le TEV ?",
"position": 16,
"acceptedAnswer": {
"@type": "Answer",
"text": "Les traitements incluent les anticoagulants, la thrombolyse et parfois la chirurgie."
}
},
{
"@type": "Question",
"name": "Comment fonctionnent les anticoagulants ?",
"position": 17,
"acceptedAnswer": {
"@type": "Answer",
"text": "Ils empêchent la formation de nouveaux caillots et aident à dissoudre les existants."
}
},
{
"@type": "Question",
"name": "Quand utiliser la thrombolyse ?",
"position": 18,
"acceptedAnswer": {
"@type": "Answer",
"text": "La thrombolyse est utilisée dans les cas graves d'embolie pulmonaire pour dissoudre rapidement le caillot."
}
},
{
"@type": "Question",
"name": "Quels sont les effets secondaires des anticoagulants ?",
"position": 19,
"acceptedAnswer": {
"@type": "Answer",
"text": "Les effets secondaires incluent des saignements, des ecchymoses et des réactions allergiques."
}
},
{
"@type": "Question",
"name": "Le traitement préventif est-il nécessaire ?",
"position": 20,
"acceptedAnswer": {
"@type": "Answer",
"text": "Oui, chez les patients à risque, un traitement préventif est souvent recommandé."
}
},
{
"@type": "Question",
"name": "Quelles sont les complications du TEV ?",
"position": 21,
"acceptedAnswer": {
"@type": "Answer",
"text": "Les complications incluent l'embolie pulmonaire, l'insuffisance veineuse et le syndrome post-thrombotique."
}
},
{
"@type": "Question",
"name": "L'embolie pulmonaire est-elle grave ?",
"position": 22,
"acceptedAnswer": {
"@type": "Answer",
"text": "Oui, l'embolie pulmonaire peut être mortelle et nécessite une attention médicale immédiate."
}
},
{
"@type": "Question",
"name": "Qu'est-ce que le syndrome post-thrombotique ?",
"position": 23,
"acceptedAnswer": {
"@type": "Answer",
"text": "C'est une complication chronique du TEV, entraînant douleur et gonflement persistants."
}
},
{
"@type": "Question",
"name": "Le TEV peut-il entraîner des problèmes cardiaques ?",
"position": 24,
"acceptedAnswer": {
"@type": "Answer",
"text": "Oui, une embolie pulmonaire peut provoquer des problèmes cardiaques en surchargeant le cœur."
}
},
{
"@type": "Question",
"name": "Comment gérer les complications du TEV ?",
"position": 25,
"acceptedAnswer": {
"@type": "Answer",
"text": "La gestion inclut un suivi médical régulier et des traitements adaptés aux complications."
}
},
{
"@type": "Question",
"name": "Quels sont les principaux facteurs de risque du TEV ?",
"position": 26,
"acceptedAnswer": {
"@type": "Answer",
"text": "Les facteurs incluent l'immobilisation, l'obésité, les antécédents familiaux et certaines maladies."
}
},
{
"@type": "Question",
"name": "L'âge influence-t-il le risque de TEV ?",
"position": 27,
"acceptedAnswer": {
"@type": "Answer",
"text": "Oui, le risque de TEV augmente avec l'âge, surtout après 60 ans."
}
},
{
"@type": "Question",
"name": "Les femmes enceintes sont-elles à risque ?",
"position": 28,
"acceptedAnswer": {
"@type": "Answer",
"text": "Oui, la grossesse augmente le risque de TEV en raison des changements hormonaux et de la circulation."
}
},
{
"@type": "Question",
"name": "Les antécédents de TEV augmentent-ils le risque ?",
"position": 29,
"acceptedAnswer": {
"@type": "Answer",
"text": "Oui, avoir des antécédents de TEV augmente significativement le risque de récidive."
}
},
{
"@type": "Question",
"name": "Le tabagisme est-il un facteur de risque ?",
"position": 30,
"acceptedAnswer": {
"@type": "Answer",
"text": "Oui, le tabagisme augmente le risque de formation de caillots sanguins."
}
}
]
}
]
}
Expert en Médecine, Optimisation des Parcours de Soins et Révision Médicale
Validation scientifique effectuée le 17/04/2025
Contenu vérifié selon les dernières recommandations médicales
5 publications dans cette catégorie
Publications dans "Thromboembolisme veineux" :
3 publications dans cette catégorie
Affiliations :
Division of Hematology, Department of Medicine, Brigham and Women's Hospital, Harvard Medical School, Boston, MA, USA.
Publications dans "Thromboembolisme veineux" :
3 publications dans cette catégorie
Affiliations :
CHU Brest, Département de Médecine Interne et Pneumologie, Brest, France; Univ_Brest, INSERM U1304-GETBO, CIC INSERM 1412, F29609 Brest; FCRIN INNOVTE network, Saint-Etienne, France. Electronic address: francis.couturaud@chu-brest.fr.
Publications dans "Thromboembolisme veineux" :
2 publications dans cette catégorie
Affiliations :
Department of Medicine, McGill University, Montreal, QC, Canada; Division of Internal Medicine and Division of Clinical Epidemiology, Jewish General Hospital/Lady Davis Institute, Montreal, QC, Canada.
Publications dans "Thromboembolisme veineux" :
2 publications dans cette catégorie
Affiliations :
Service d'angiologie et d'hémostase, HUG, 1211 Genève 14, et Faculté de médecine, Université de Genève, 1211 Genève 4.
Publications dans "Thromboembolisme veineux" :
2 publications dans cette catégorie
Affiliations :
Children's Hospital of Philadelphia, Philadelphia, Pennsylvania, USA.
Publications dans "Thromboembolisme veineux" :
2 publications dans cette catégorie
Affiliations :
Children's Hospital of Philadelphia, Philadelphia, Pennsylvania, USA.
Publications dans "Thromboembolisme veineux" :
2 publications dans cette catégorie
Affiliations :
Institute of Pharmacology, University of Bern, Bern, Switzerland.
Publications dans "Thromboembolisme veineux" :
2 publications dans cette catégorie
Affiliations :
Clinic of Angiology, University Hospital Zurich, Zurich, Switzerland.
Publications dans "Thromboembolisme veineux" :
2 publications dans cette catégorie
Affiliations :
Clinic of Angiology, University Hospital Zurich, Zurich, Switzerland.
Publications dans "Thromboembolisme veineux" :
2 publications dans cette catégorie
Affiliations :
Department of Internal Medicine, Cantonal Hospital Baden, Baden, Switzerland.
Publications dans "Thromboembolisme veineux" :
2 publications dans cette catégorie
Affiliations :
Clinic of Angiology, University Hospital Lausanne, Lausanne, Switzerland.
Publications dans "Thromboembolisme veineux" :
2 publications dans cette catégorie
Affiliations :
Department of Internal Medicine, University Hospital Basel, Basel, Switzerland.
Publications dans "Thromboembolisme veineux" :
2 publications dans cette catégorie
Affiliations :
Division of General Internal Medicine, Bern University Hospital, Bern, Switzerland.
Publications dans "Thromboembolisme veineux" :
2 publications dans cette catégorie
Affiliations :
Department of Internal Medicine, Cantonal Hospital Fribourg, Villars-sur-Glâne, Switzerland.
Publications dans "Thromboembolisme veineux" :
2 publications dans cette catégorie
Affiliations :
Department of Internal Medicine, Cantonal Hospital Fribourg, Villars-sur-Glâne, Switzerland.
Publications dans "Thromboembolisme veineux" :
2 publications dans cette catégorie
Affiliations :
Department of Internal Medicine, Cantonal Hospital Obwalden, Sarnen, Switzerland.
Publications dans "Thromboembolisme veineux" :
2 publications dans cette catégorie
Affiliations :
Department of Internal Medicine, Cantonal Hospital St. Gallen, St. Gallen, Switzerland.
Publications dans "Thromboembolisme veineux" :
2 publications dans cette catégorie
Affiliations :
Department of Internal Medicine, Regional Hospital Burgdorf, Burgdorf, Switzerland.
Publications dans "Thromboembolisme veineux" :
2 publications dans cette catégorie
Affiliations :
Clinic of Angiology, University Hospital Zurich, Zurich, Switzerland.
Publications dans "Thromboembolisme veineux" :
The role and potential molecular mechanism of inflammatory cells in pediatric localized scleroderma are poorly investigated. In this study, we first investigated the profiling of inflammatory cells in...
Connective tissue nevi (CTN) are congenital hamartomas caused by excessive proliferation of dermis components. In children, CTN can mimic juvenile localized scleroderma (JLS), an immune mediated skin ...
Aim of our study was to describe a series of pediatric patients with CTN misdiagnosed as JLS and the discerning characteristics between the two conditions....
Retrospective analysis of children referred to our Center during the last two decades for JLS who received a final diagnosis of CTN. Clinical, laboratory, histopathological and instrumental data (MRI ...
Seventeen patients with mean age at onset 4.6 years entered the study. All came to our Center with a certain diagnosis of JLS (n = 15) or suspected JLS (n = 2). The indurated skin lesions were flat an...
CTN can be misdiagnosed as JLS and therefore aggressively treated with prolonged and inappropriate immunosuppression. The absence of inflammatory appearance of the skin lesions, normal instrumental an...
Juvenile localized scleroderma (JLS) or morphoea, a rare chronic autoimmune disease predominantly affects skin, subcutaneous tissue and occasionally the adjacent muscle, fascia and bone. We report the...
Patients who were diagnosed to have JLS were enrolled from the Paediatric Dermatology Clinic and the Paediatric Rheumatology Clinic of a tertiary care referral hospital in India. Collected data includ...
We analysed 84 patients with Juvenile localized scleroderma. Median age of disease onset was 5 years, and median age at diagnosis was 8 years. Commonest subtype was linear scleroderma (57 patients, 67...
Early use of systemic corticosteroids along with methotrexate may be more beneficial than methotrexate therapy alone....
Current treatment for localized scleroderma (LS) has been shown to halt disease activity, but little is still known about patient experiences with these treatments, nor is there consensus about optima...
Conduct a scoping review of the literature for the types of outcomes and measures (i.e. clinician-, patient-, and caregiver-reported) utilized in published treatment studies of LS....
Online databases were searched for articles related to the evaluation of treatment efficacy in LS with a special focus on pediatrics....
Of the 168 studies, the most common outcomes used were cutaneous disease activity and damage measured via clinician-reported assessments. The most frequently cited measure was the Localized Scleroderm...
Some studies only vaguely reported the measures utilized, and the review yielded a low number of clinical trials....
In addition to evaluating disease activity with clinician-reported measures, the field could obtain critical knowledge on the patient experience by including high-quality PROMs of symptoms and functio...
Infrared thermography (IRT) is a useful method to detect activity/inflammation in localized scleroderma (LoS); however, inactive skin lesions with a severe degree of dermal and subcutaneous atrophy ma...
The aim of this research was to compare the spectrophotometric results with thermographic examination of LoS lesions....
The lesions were assessed using the Localized Scleroderma Assessment Tool (LoSCAT), Dyspigmentation, Induration, Erythema, and Telangiectasias (DIET) score, NBRS and IRT. The difference in the erythem...
Fifty-five patients with 49 active and 64 inactive LoS lesions were examined. The ΔEI strongly correlated with the erythema (r...
Narrow-band reflectance spectrophotometry may be a complementary method for determining erythema in LoS active lesions, although this technique remains inferior to IRT, because is unable to distinct b...
Localized scleroderma (LS) is an autoimmune disease with both inflammatory and fibrotic components causing an abnormal deposition of collagen in the skin and underlying tissue, often leading to disfig...
Localized scleroderma (LS) is characterized by skin fibrosis, hyperpigmentation and soft tissue atrophy. Fat grafting has been widely used to correct LS deformity....
To investigate the effect of fat grafting on the skin pigmentation of LS lesions....
A prospective self-controlled study was conducted. Skin melanin and erythema indexes were measured by Mexameter® MX18 before and 3 months after surgery. Differences between lesions and contralateral n...
Fourteen frontal linear LS patients participated in the study. Before surgery, the melanin index of the lesions was significantly higher than the contralateral sites (p = 0.023), while the erythema in...
Fat grafting could alleviate skin hyperpigmentation and skin damage of LS lesions while having little effect on skin erythema and disease activity....
This journal requires that authors assign a level of evidence to each article. For a full description of these Evidence-Based Medicine ratings, please refer to the Table of Contents or the online Inst...
Scleroderma is a rare complication in taxanes therapy. Although individual cases of taxanes-induced scleroderma have been reported, the clinical manifestation and treatment outcomes were reviewed and ...
A PubMed literature review on published cases of taxanes-induced scleroderma up until April 2022 was included for analysis....
The search identified 27 patients with adequate information for analysis. Of the 28 patients, including the one presented here, 22 were female. Peripheral edema was the most common symptom in all but ...
Taxanes-induced scleroderma is different from idiopathic scleroderma. Physicians should be aware of this condition in order to provide early diagnosis and apply appropriate management in order to avoi...
Localized scleroderma (LS) is an autoimmune disease characterized by inflammation and fibrosis, leading to severe cutaneous manifestations such as skin hardening, tightness, discoloration, and other t...
Juvenile localized and systemic scleroderma are rare autoimmune diseases which cause significant disability and morbidity in children. The mechanisms driving juvenile scleroderma remain unclear, neces...